Trades on 4 secondary markets

Vial

Vial is a next-generation biotech company advancing first and best-in-class biologics to treat unmet need in Immunology and Inflammation. The company pairs AI-driven drug discovery with automated, technology-enabled clinical trials, working across target discovery (identifying high-value therapeutic

minimal 10.8 / 100 0 APIs View provider profile →

Company Biotech Life Sciences Clinical Trials Drug Discovery Immunology

Vial is an API provider whose private shares are listed on 4 secondary markets: Forge Global, Hiive, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.